152 related articles for article (PubMed ID: 32382514)
21. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
[TBL] [Abstract][Full Text] [Related]
22. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
[TBL] [Abstract][Full Text] [Related]
23. Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.
Fox E; Levin K; Zhu Y; Segers B; Balamuth N; Womer R; Bagatell R; Balis F
Oncologist; 2018 Jul; 23(7):762-e79. PubMed ID: 29445029
[TBL] [Abstract][Full Text] [Related]
24. Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers.
Bunel V; Tournay Y; Baudoux T; De Prez E; Marchand M; Mekinda Z; Maréchal R; Roumeguère T; Antoine MH; Nortier JL
Clin Kidney J; 2017 Oct; 10(5):639-647. PubMed ID: 28979774
[TBL] [Abstract][Full Text] [Related]
25. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.
Zhou Y; Vaidya VS; Brown RP; Zhang J; Rosenzweig BA; Thompson KL; Miller TJ; Bonventre JV; Goering PL
Toxicol Sci; 2008 Jan; 101(1):159-70. PubMed ID: 17934191
[TBL] [Abstract][Full Text] [Related]
26. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
[TBL] [Abstract][Full Text] [Related]
27. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
Waring WS; Moonie A
Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.
Hartmann JT; Fels LM; Knop S; Stolt H; Kanz L; Bokemeyer C
Invest New Drugs; 2000 Aug; 18(3):281-9. PubMed ID: 10958599
[TBL] [Abstract][Full Text] [Related]
29. Urine NGAL and KIM-1-Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study.
Latoch E; Konończuk K; Muszyńska-Rosłan K; Taranta-Janusz K; Wasilewska A; Szymczak E; Trochim J; Krawczuk-Rybak M
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33494327
[TBL] [Abstract][Full Text] [Related]
30. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury.
Vaidya VS; Ramirez V; Ichimura T; Bobadilla NA; Bonventre JV
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F517-29. PubMed ID: 16174863
[TBL] [Abstract][Full Text] [Related]
31. Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma.
Hosohata K; Washino S; Kubo T; Natsui S; Fujisaki A; Kurokawa S; Ando H; Fujimura A; Morita T
Toxicology; 2016 Jun; 359-360():71-5. PubMed ID: 27317936
[TBL] [Abstract][Full Text] [Related]
32. Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.
Pedram B; Moghadam AT; Kamyabi-Moghaddam Z; Mavedati O; Beigi BA; Sharabiyani AK; Dezfuli AB; Khalili S; Bahrami AM; Nasoori A
Tumour Biol; 2015 Jun; 36(6):4495-500. PubMed ID: 25596088
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 10 Urinary Biomarkers for Renal Safety With 5 Nephrotoxicants in Nonhuman Primates.
Vlasakova K; Troth SP; Sistare FD; Glaab WE
Toxicol Pathol; 2020 Jul; 48(5):633-648. PubMed ID: 32633702
[TBL] [Abstract][Full Text] [Related]
34. Time course of organic anion transporter 5 (Oat5) urinary excretion in rats treated with cisplatin: a novel urinary biomarker for early detection of drug-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2015 Aug; 89(8):1359-69. PubMed ID: 25164828
[TBL] [Abstract][Full Text] [Related]
35. Multiscale Mathematical Model of Drug-Induced Proximal Tubule Injury: Linking Urinary Biomarkers to Epithelial Cell Injury and Renal Dysfunction.
Gebremichael Y; Lu J; Shankaran H; Helmlinger G; Mettetal J; Hallow KM
Toxicol Sci; 2018 Mar; 162(1):200-211. PubMed ID: 29126144
[TBL] [Abstract][Full Text] [Related]
36. Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial.
Ghonaim E; El-Haggar S; Gohar S
Med Oncol; 2021 Aug; 38(9):108. PubMed ID: 34357466
[TBL] [Abstract][Full Text] [Related]
37. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
Succar L; Pianta TJ; Davidson T; Pickering JW; Endre ZH
Kidney Int; 2017 Sep; 92(3):680-692. PubMed ID: 28476556
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
39. The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors.
Hartmann JT; Knop S; Fels LM; van Vangerow A; Stolte H; Kanz L; Bokemeyer C
Anticancer Drugs; 2000 Jan; 11(1):1-6. PubMed ID: 10757556
[TBL] [Abstract][Full Text] [Related]
40. Impaired Tubular Reabsorption Is the Main Mechanism Explaining Increases in Urinary NGAL Excretion Following Acute Kidney Injury in Rats.
Sancho-Martínez SM; Blanco-Gozalo V; Quiros Y; Prieto-García L; Montero-Gómez MJ; Docherty NG; Martínez-Salgado C; Morales AI; López-Novoa JM; López-Hernández FJ
Toxicol Sci; 2020 May; 175(1):75-86. PubMed ID: 32110797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
